NCT07243873 Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter Study
| NCT ID | NCT07243873 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shanghai Pulmonary Hospital, Shanghai, China |
| Condition | Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2025-12-01 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to synthesise PET data that preserves biological relevance and adds clinical value to the diagnosis and prognosis of lung cancer by establishing anatomical-to-metabolic mapping based on paired diagnostic CT and FDG-PET scans, thereby prospectively validating the clinical utility of the model.
Eligibility Criteria
Inclusion Criteria: 1. Patients with non-small cell lung cancer scheduled to undergo PET-CT and pathological examinations; 2. Voluntarily participate and sign an informed consent form; Exclusion Criteria: 1. History of other malignant tumours; 2. Image artefacts; 3. Without pathological diagnostic information; 4. Without paired CT and FDG-PET scan images.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07243873 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07243873 currently recruiting?
Yes, NCT07243873 is actively recruiting participants. Contact the research team at shenxinchen9@163.com for enrollment information.
Where is the NCT07243873 trial being conducted?
This trial is being conducted at Zunyi, China, Jiangxi, China, Shanghai, China, Shanghai, China and 1 additional location.
Who is sponsoring the NCT07243873 clinical trial?
NCT07243873 is sponsored by Shanghai Pulmonary Hospital, Shanghai, China. The trial plans to enroll 10,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.